E. Ohman J or Asset Management AB Has $3.56 Million Stock Position in CVS Health Corporation $CVS

E. Ohman J or Asset Management AB cut its position in CVS Health Corporation (NYSE:CVS) by 14.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 44,905 shares of the pharmacy operator’s stock after selling 7,540 shares during the quarter. E. Ohman J or Asset Management AB’s holdings in CVS Health were worth $3,564,000 at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. Harbor Capital Advisors Inc. boosted its holdings in CVS Health by 72.1% during the third quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock valued at $26,000 after acquiring an additional 142 shares during the period. Caitong International Asset Management Co. Ltd increased its stake in shares of CVS Health by 407.2% in the third quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 281 shares during the period. Corundum Trust Company INC acquired a new position in shares of CVS Health during the 3rd quarter worth about $29,000. GoalVest Advisory LLC bought a new stake in CVS Health during the 4th quarter valued at approximately $32,000. Finally, Front Row Advisors LLC boosted its stake in CVS Health by 436.5% during the 2nd quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock valued at $31,000 after purchasing an additional 371 shares during the period. Institutional investors own 80.66% of the company’s stock.

CVS Health Stock Down 0.3%

Shares of CVS opened at $71.26 on Tuesday. The company has a quick ratio of 0.63, a current ratio of 0.84 and a debt-to-equity ratio of 0.80. The company has a 50-day moving average price of $77.30 and a two-hundred day moving average price of $77.82. The stock has a market cap of $90.66 billion, a price-to-earnings ratio of 51.64, a P/E/G ratio of 0.75 and a beta of 0.49. CVS Health Corporation has a 12 month low of $58.35 and a 12 month high of $85.15.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating the consensus estimate of $1.00 by $0.09. The company had revenue of $105.69 billion for the quarter, compared to analyst estimates of $103.67 billion. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.The company’s revenue was up 8.2% compared to the same quarter last year. During the same period in the prior year, the company posted $1.19 EPS. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. Equities analysts predict that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, May 4th. Shareholders of record on Thursday, April 23rd will be paid a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 3.7%. The ex-dividend date is Thursday, April 23rd. CVS Health’s dividend payout ratio is currently 192.75%.

Analysts Set New Price Targets

CVS has been the topic of several recent analyst reports. Mizuho lifted their price target on CVS Health from $88.00 to $95.00 and gave the stock an “outperform” rating in a research report on Wednesday, December 10th. Truist Financial set a $100.00 price objective on shares of CVS Health in a research note on Wednesday, December 10th. Piper Sandler reaffirmed an “overweight” rating and set a $101.00 target price (up from $99.00) on shares of CVS Health in a research report on Wednesday, December 10th. TD Cowen reiterated a “buy” rating on shares of CVS Health in a research note on Friday, March 13th. Finally, Robert W. Baird raised their price target on shares of CVS Health from $82.00 to $92.00 and gave the stock an “outperform” rating in a research report on Wednesday, December 10th. Twenty investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $95.05.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.